Prashant Nagpal, Ph.D
Co-Founder and Vice-President of ARC Laboratories
Dr. Prashant Nagpal has more than 15 years of experience in nanoscience and nanotechnology, quantum biology, molecularspectroscopy, and physical chemistry. He is the co-inventor of FAST technology. Prashant received his B.S. from Indian Institute of Technology Delhi in 2004, and earned his Ph.D. from University of Minnesota in 2009. After working for 2.5 years at Los Alamos National Laboratory as a post-doctoral scholar, he joined the University of Colorado Boulder in August 2012. His research has been published in more than 50 publications in peer reviewed, high-impact journals such as Science, Nature Materials, Nature Communications, Physical Review Letters, Nano Letters, JACS, ACS Nano, Angewandte Chemie, and he has filed and granted more than 20 patents based on his work, given over 50 invited talks, and has received numerous awards and honors including the New Inventor of the Year Award (2013), NSF CAREER Award (2014), Keck Foundation Research Award (2015), Outstanding Junior Faculty Award by University of Colorado (2017), and more recently, Emerging Leader in Biological Engineering award (2019). His work has been highlighted in more than 100 national and international print and media outlets, and was recently featured in ABC Evening News, France 24, BBC, Newsweek, MSN, Times of India, R&D Magazine, Outlook, Indian Express, Huffington Post, Popular Mechanics, Daily Mail, The Statesman, and KGNU’s Science show “How on Earth”. Besides ARC Labs He has also founded two biotech startup companies.


Light-powered nano-organisms consume CO2, create eco-friendly plastics and fuels, press release

Rapid, cost-effective genetic screening within reach, press release

Light-activated nanoparticles can supercharge current antibiotics, press release

Tiny Quantum Dots May Spell Doom For Deadly Superbug Infections, press

COVID-19: ACE, Targeted Therapies, Old & New Medicines, How on Earth - The KGNU Science Show, listen here

Six grand ideas to fight the end of antibiotics, BBC article

Selected Publications

Gold nanoclusters cause selective light-driven biochemical catalysis in living nano-biohybrid organisms”Bertram J.R., Ding Y., Nagpal P.*, Nanoscale Advances, DOI: 10.1039/D0NA00017E (2020). (Link)

Diagnostic optical sequencing”Korshoj L.E., Nagpal P.*, ACS Applied Materials and Interfaces, 11, 35587 (2019). (Link)  

Near-infrared light triggered antimicrobial indium phosphide quantum dots”Levy M., Bertram J.R., Eller, K.A., Chatterjee A., Nagpal P.*, Angewandte Chemie International Edition, 58, 11414 (2019). (Link)

Nanorg microbial factories: Light-driven renewable biochemical synthesis using quantum dot-bacteria nano-biohybrids”Ding Y., Bertram J.R., Eckert C., Bommareddy R.R., Patel R., Conradie A., Bryan S., Nagpal P.*, Journal of the American Chemical Society, 141, 10272 (2019). (Link)

Quantum dot therapeutics: a new class of radical therapies”Levy M., Chowdhury P.P., Nagpal P.*, Journal of Biological Engineering, 13:48 (2019). (Link)

Nucleotide and structural label identification in single RNA molecules with quantum tunneling spectroscopy”Abel G.A., Korshoj L.E., Otoupal P.B., Khan S.K., Chatterjee A., Nagpal P.*, Chemical Science , 10, 1052 (2019). (Link)

Assessing different reactive oxygen species as potential antibiotics: Selectivity of intracellular superoxide generation using quantum dots”Levy M.,Courtney C.M., Chowdhury P.P.,Ding Y.,Grey E.L., Goodman S.M., Chatterjee A., Nagpal P.*, ACS Applied BioMaterials , 1, 529 (2018). (Link)  

Quantum point contact single-nucleotide conductance for DNA and RNA sequence identification”,Afsari S., Korshoj L.E., Abel G.A., Khan S.K., Chatterjee A., Nagpal P.*, ACS Nano , 11, 11169 (2017).(Link)

Potentiating antibiotics in drug-resistant clinical isolates via stimuli-activated superoxide generation”,Courtney C.M., Goodman S.M., Nagy T.A., Levy M., Bhusal P., Madinger N.E., Detweiler C.S., Nagpal P.*, Chatterjee A.*, Science Advances,3, e1701776(2017). (Link)

"Photoexcited quantum dots for killing multidrug-resistant bacteria"Courtney C.M., Goodman S.M., McDaniel J.A., Madinger N.E., Chatterjee A.*, Nagpal P.*, Nature Materials,15, 529 (2016). (Link)
All Publications and Patents